ArticleTranslational lung cancer research2022

Circulating tumor DNA predicts neoadjuvant immunotherapy efficacy and recurrence-free survival in surgical non-small cell lung cancer patients.

Dongsheng Yue et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.